FDA Advisory Committee to review Johnson & Johnson's (JNJ) COVID-19 vaccine on Feb 26th

February 10, 2021 8:55 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

FDA Advisory Committee to review Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine on Feb 26th.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Trader Talk

Related Entities

AdCom, FDA